Grants and Contributions:

Back to search

Title:

High throughput screening platform to accelerate development of drugs targeting neurological diseases

Agreement Number:

916584

Agreement Value:

$81,000.00

Agreement Date:

Nov 5, 2018 - Feb 28, 2020

Description:

Ananda Devices' proprietary Neuro-microfluidic device (MFD) offers a more efficient model to test drugs targeting neurological diseases in vitro. The Neuro-MFD enables up to 90% cost reduction with reagents and samples and up to 50% faster data analysis in cultures of humans-derived neurons. However, each Neuro-MFD can only test one drug per experiment. To sell to the biopharmaceutical industry market, here we propose to adapt the Neuro-MFD to the industry standard high throughput screening (HTS) plate format, enabling testing of thousands of drugs/experimental conditions.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Montreal, Quebec, CA H4R 3E9

Reference Number:

172-2018-2019-Q3-916584

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

799217898

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 210 days.

Amendment Date

Jul 10, 2019

Recipient's Legal Name:

9493662 CANADA Inc

Federal Riding Name:

Saint-Laurent

Federal Riding Number:

24068

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54199

Amendments:

See Amendments